These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8203859

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections.
    Gupta CM, Haq W.
    Methods Enzymol; 2005; 391():291-304. PubMed ID: 15721387
    [Abstract] [Full Text] [Related]

  • 3. Tuftsin-bearing liposomes as drug vehicles in the treatment of experimental aspergillosis.
    Owais M, Ahmed I, Krishnakumar B, Jain RK, Bachhawat BK, Gupta CM.
    FEBS Lett; 1993 Jul 12; 326(1-3):56-8. PubMed ID: 8325389
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tuftsin-bearing liposomes in treatment of macrophage-based infections.
    Agrawal AK, Gupta CM.
    Adv Drug Deliv Rev; 2000 Mar 30; 41(2):135-46. PubMed ID: 10699310
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.
    Khan MA, Nasti TH, Owais M.
    J Antimicrob Chemother; 2005 Oct 30; 56(4):726-31. PubMed ID: 16126780
    [Abstract] [Full Text] [Related]

  • 8. Drug targeting in Leishmania donovani infections using tuftsin-bearing liposomes as drug vehicles.
    Guru PY, Agrawal AK, Singha UK, Singhal A, Gupta CM.
    FEBS Lett; 1989 Mar 13; 245(1-2):204-8. PubMed ID: 2538359
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes.
    Labana S, Pandey R, Sharma S, Khuller GK.
    Int J Antimicrob Agents; 2002 Oct 13; 20(4):301-4. PubMed ID: 12385689
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA, Khan A, Owais M.
    FEMS Immunol Med Microbiol; 2006 Feb 13; 46(1):63-9. PubMed ID: 16420598
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice.
    Deol P, Khuller GK, Joshi K.
    Antimicrob Agents Chemother; 1997 Jun 13; 41(6):1211-4. PubMed ID: 9174172
    [Abstract] [Full Text] [Related]

  • 13. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R, Sharma S, Khuller GK.
    Int J Antimicrob Agents; 2004 Apr 13; 23(4):414-5. PubMed ID: 15081096
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections.
    Vall-Spinosa A, Lester W, Moulding T, Davidson PT, McClatchy JK.
    N Engl J Med; 1970 Sep 17; 283(12):616-21. PubMed ID: 4988918
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The use of rifampicin and isoniazid entrapped in liposomes for the treatment of Murine tuberculosis.
    Orozco LC, Quintana FO, Beltrán RM, de Moreno I, Wasserman M, Rodriguez G.
    Tubercle; 1986 Jun 17; 67(2):91-7. PubMed ID: 3775869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.